L & S Advisors Inc Gilead Sciences, Inc. Transaction History

L & S Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $792,408 - $1.03 Million	-13,089 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $932,983 - $1.03 Million	13,089 New	13,089 $1.01 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $6.3 Million - $7.39 Million	-88,531 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $6.38 Million - $7.57 Million	88,531	88,531 $7.17 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.